Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PARP10 | Q53GL7 | 12/20 | 1.00 |
| ▸ | PARP1 | P09874 | 10/20 | 1.00 |
| ▸ | PARP11 | Q9NR21 | 8/20 | 1.00 |
| ▸ | PDPK1 | O15530 | 1/20 | 1.00 |
| ▸ | CA12 | O43570 | 1/20 | 0.63 |
| ▸ | CA9 | Q16790 | 1/20 | 0.63 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.58 |
| ▸ | TUBB | P07437 | 1/20 | 0.58 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.58 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.58 |
| ▸ | TUBA4A | P68366 | 1/20 | 0.58 |
| ▸ | TUBB4B | P68371 | 1/20 | 0.58 |
| ▸ | TUBB3 | Q13509 | 1/20 | 0.58 |
| ▸ | TUBB2A | Q13885 | 1/20 | 0.58 |
| ▸ | TUBB8 | Q3ZCM7 | 1/20 | 0.58 |
| ▸ | TUBA3E | Q6PEY2 | 1/20 | 0.58 |
| ▸ | TUBA1A | Q71U36 | 1/20 | 0.58 |
| ▸ | TUBA1C | Q9BQE3 | 1/20 | 0.58 |
| ▸ | TUBB6 | Q9BUF5 | 1/20 | 0.58 |
| ▸ | TUBB2B | Q9BVA1 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29369705 | 1.00 | PARP10 (1.00) | PARP10PARP1PARP11PDPK1CA12 | |
| Hydrochloric Acid SCHEMBL29896921 | 0.98 | PARP10 (0.96) | PARP10PARP1PARP11PDPK1CA12 | |
| Hydrochloric Acid SCHEMBL10647408 | 0.98 | PARP10 (0.96) | PARP10PARP1PARP11PDPK1CA12 | |
| Piperazine SCHEMBL28321362 | 0.94 | PARP10 (0.89) | PARP10PARP1PARP11PDPK1CA12 | |
| SCHEMBL1894080 | 0.88 | PARP10 (0.78) | PARP10PARP1PARP11PDPK1CA12 | |
| SCHEMBL20076060 | 0.86 | PARP10 (0.75) | PARP10PARP1PARP11PDPK1CA12 | |
| SCHEMBL29752161 | 0.86 | PARP10 (0.75) | PARP10PARP1PARP11PDPK1CA12 | |
| Trifluoroacetic Acid SCHEMBL28415123 | 0.85 | PARP10 (0.72) | PARP10PARP1PARP11PDPK1CA12 | |
| SCHEMBL28691391 | 0.82 | PARP1 (0.68) | PARP10PARP1PARP11PDPK1CA12 | |
| SCHEMBL30114663 | 0.81 | PARP10 (0.67) | PARP10PARP1PARP11PDPK1CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3021 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4737443-A1 | SALT-INDUCIBLE KINASE INHIBITORY COMPOUND AND PHARMACEUTICAL COMPOSITION CONTAINING SAME | Tanabe Pharma Corporation (JP) | 2026-05-06 | — | — | EP | claimed |
| EP-3768675-B1 | NOVEL TRIAZOLONE DERIVATIVES OR SALTS THEREOF AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME | YUHAN CORP (KR) | 2026-04-01 | — | — | EP | claimed |
| US-20260062387-A1 | SALT-INDUCIBLE KINASE INHIBITOR COMPOUND AND PHARMACEUTICAL COMPOSITION INCLUDING THE SAME | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2026-03-05 | — | — | US | claimed |
| US-20250388599-A1 | TRICYCLIC PI3K INHIBITOR COMPOUNDS AND METHODS OF USE | GENENTECH INC (US) | 2025-12-25 | — | — | US | claimed |
| EP-4653437-A2 | NOVEL HETEROCYCLIC COMPOUNDS | Innovo Therapeutics Inc. (KR) | 2025-11-26 | — | — | EP | claimed |
| EP-4611899-A1 | ALLOSTERIC CHROMENONE INHIBITORS OF PHOSPHOINOSITIDE 3-KINASE (PI3K) FOR THE TREATMENT OF DISEASE | Petra Pharma Corporation (US) | 2025-09-10 | — | — | EP | claimed |
| WO-2025064641-A1 | SYNTHETIC COMPOUNDS COMPRISING DIHYDROISOQUINOLINONE MONOMERS | SRI INTERNATIONAL (US) | 2025-03-27 | — | — | WO | claimed |
| EP-4514784-A1 | ALLOSTERIC CHROMENONE INHIBITORS OF PHOSPHOINOSITIDE 3-KINASE (PI3K) FOR THE TREATMENT OF DISEASE | Petra Pharma Corporation (US) | 2025-03-05 | — | — | EP | claimed |
| EP-4050006-B1 | BICYCLIC COMPOUND AND USE THEREOF | SK BIOPHARMACEUTICALS CO LTD (KR) | 2025-01-01 | — | — | EP | claimed |
| WO-2024242169-A1 | SALT-INDUCIBLE KINASE INHIBITORY COMPOUND AND PHARMACEUTICAL COMPOSITION CONTAINING SAME | 田辺三菱製薬株式会社 | 2024-11-28 | — | — | WO | claimed |
| EP-0575749-A2 | Use of potassium-channel activators for the manufacture of a medicament for the treatment of gastrointertinal ulcers | E.R. SQUIBB & SONS, INC. (US) | 1993-12-29 | — | — | EP | claimed |
| US-5262419-A | Antiulcer agents | E. R. SQUIBB & SONS, INC. (US) | 1993-11-16 | — | — | US | claimed |
| EP-0528553-A1 | Tetrahydroisoquinoline derivatives, processes for producing the same and fungicides containing the same | TOSOH CORPORATION (JP) | 1993-02-24 | — | — | EP | claimed |
| EP-0250077-B1 | PHARMACOLOGICALLY ACTIVE BENZOPYRANES | BEECHAM GROUP PLC (GB) | 1992-01-02 | — | — | EP | claimed |
| EP-0205292-B1 | Pyrano[3,2-c]pyridine derivatives, process and intermediates for their preparation and pharmaceutical compositions containing them | BEECHAM GROUP PLC (GB) | 1991-11-06 | — | — | EP | claimed |
| EP-0372998-A2 | Use of benzopyran derivatives in the treatment of epilepsy | BEECHAM GROUP PLC (GB) | 1990-06-13 | — | — | EP | claimed |
| EP-0250077-A2 | Pharmacologically active benzopyranes | BEECHAM GROUP PLC (GB) | 1987-12-23 | — | — | EP | claimed |
| WO-1987007607-A1 | PYRANO (3,2-c) PYRIDINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | BEECHAM GROUP P.L.C. (GB) | 1987-12-17 | — | — | WO | claimed |
| EP-0205292-A2 | Pyrano[3,2-c]pyridine derivatives, process and intermediates for their preparation and pharmaceutical compositions containing them | BEECHAM GROUP PLC (GB) | 1986-12-17 | — | — | EP | claimed |
| EP-0096006-A2 | 3-(Ureidocyclohexylamino)-propane-1,2-diol derivatives, process for their preparation, pharmaceutical preparations containing these compounds and their therapeutical use | CIBA-GEIGY AG (CH) | 1983-12-07 | — | — | EP | claimed |